Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Killar, Ja"'
Autor:
Steigbigel, Rt, Cooper, Da, Kumar, Pn, Eron, Je, Schechter, M, Markowitz, M, Loutfy, Vullo, Vincenzo, Lennox, Jl, Gatell, Jm, Rockstroh, Jk, Katlama, C, Yeni, P, Lazzarin, A, Clotet, B, Zhao, J, Chen, J, Ryan, Dm, Rhodes, Rr, Killar, Ja, Gilde, Lr, Strohmaier, Km, Meibohm, Ar, Miller, Md, Hazuda, Dj, Nessly, Ml, Dinubile, Mj, Isaacs, Rd, Nguyen, By, Teppler, H, BENCHMRK STUDY TEAMS
Background: Raltegravir (MK-0518) is an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase active against HIV-1 susceptible or resistant to older antiretroviral drugs. Methods: We conducted two identical trials in different geographic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce129d1ea451fff329dd3bee80d5d2a
http://hdl.handle.net/11573/85776
http://hdl.handle.net/11573/85776
Autor:
Cooper, Da, Steigbigel, Rt, Gatell, Jm, Rockstroh, Jk, Katlama, C, Yeni, P, Lazzarin, A, Clotet, B, Kumar, Pn, Eron, Je, Schechter, M, Markowitz, M, Loutfy, Mr, Lennox, Jl, Zhao, J, Chen, J, Ryan, Dm, Rhodes, Rr, Killar, Ja, Gilde, Lr, Strohmaier, Vullo, Vincenzo, Meibohm, Ar, Miller, Md, Hazuda, Dj, Nessly, Ml, Dinubile, Mj, Isaacs, Rd, Teppler, H, Nguyen, By, BENCHMRK STUDY TEAMS
Background: We evaluated the efficacy of raltegravir and the development of viral resistance in two identical trials involving patients who were infected with human immunodeficiency virus type 1 (HIV-1) with triple-class drug resistance and in whom a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acfd904b9414218980a2d17b85e46901
http://hdl.handle.net/11573/85775
http://hdl.handle.net/11573/85775
Autor:
Steigbigel RT (AUTHOR), Cooper DA (AUTHOR), Kumar PN (AUTHOR), Eron JE (AUTHOR), Schechter M (AUTHOR), Markowitz M (AUTHOR), Loutfy MR (AUTHOR), Lennox JL (AUTHOR), Gatell JM (AUTHOR), Rockstroh JK (AUTHOR), Katlama C (AUTHOR), Yeni P (AUTHOR), Lazzarin A (AUTHOR), Clotet B (AUTHOR), Zhao J (AUTHOR), Chen J (AUTHOR), Ryan DM (AUTHOR), Rhodes RR (AUTHOR), Killar JA (AUTHOR), Gilde LR (AUTHOR)
Publikováno v:
New England Journal of Medicine. 7/24/2008, Vol. 359 Issue 4, p339-354. 16p.
Autor:
Cooper DA (AUTHOR), Steigbigel RT (AUTHOR), Gatell JM (AUTHOR), Rockstroh JK (AUTHOR), Katlama C (AUTHOR), Yeni P (AUTHOR), Lazzarin A (AUTHOR), Clotet B (AUTHOR), Kumar PN (AUTHOR), Eron JE (AUTHOR), Schechter M (AUTHOR), Markowitz M (AUTHOR), Loutfy MR (AUTHOR), Lennox JL (AUTHOR), Zhao J (AUTHOR), Chen J (AUTHOR), Ryan DM (AUTHOR), Rhodes RR (AUTHOR), Killar JA (AUTHOR), Gilde LR (AUTHOR)
Publikováno v:
New England Journal of Medicine. 7/24/2008, Vol. 359 Issue 4, p355-365. 11p.
Autor:
Martinón-Torres F; From the *Translational Pediatrics and Infectious Diseases, Department of Pediatrics, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Galicia, Spain; †Grupo de Investigación en Genética, Vacunas, Infecciones y Pediatría (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidade de Santiago de Compostela (USC), Galicia, Spain; §Soroka University Medical Center, Pediatric Infectious Disease Unit, Beer Sheva, Israel; ¶Department of Pediatrics, Creighton University, Omaha, Nebraska; and ‖Merck & Co., Inc., Merck Research Laboratories, Kenilworth, New Jersey., Greenberg D, Varman M, Killar JA, Hille D, Strable EL, Stek JE, Kaplan SS
Publikováno v:
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2017 Apr; Vol. 36 (4), pp. 417-422.